Effects of SW 33377, SW 68210 and SW 71425 thioxanthones on in vitro colony formation of freshly explanted human tumor cells

• Published in: Investigational new drugs Vol. 16; no. 3; pp. 221 - 225
• Main Authors: IZBICKA, E, LAWRENCE, R, DAVIDSON, K, RAKE, J. B, VON HOFF, D. D
• Format: Journal Article
• Language: English
• Published: Dordrecht Kluwer 01-01-1998; Springer Nature B.V
• Subjects: Antineoplastic agents; Antineoplastic Agents - pharmacology; Biological and medical sciences; Biosynthesis; Clinical trials; Cloning; Colon; Drug dosages; Drug Screening Assays, Antitumor; General aspects; Humans; Hydrocarbons; Medical sciences; Ovarian cancer; Penicillin; Pharmacology. Drug treatments; Sulfonamides - pharmacology; Thioxanthenes - pharmacology; Toxicity; Tumor Cells, Cultured; Tumors; Antineoplastic agent; Human; Thio complex; Xanthone; Intercalating agent; Enzyme; Toxicity; DNA topoisomerase; Enzyme inhibitor; Malignant tumor; In vitro; Biological activity; Isomerases; Mechanism of action; Tumor cell
• ISSN: 0167-6997; 1573-0646
• DOI: 10.1023/A:1006152100299

Thioxanthones are aromatic hydrocarbons with cytotoxic activity against several tumor models. Potential mechanisms of action may include DNA intercalation, inhibition of nucleic acid biosynthesis, and topoisomerase inhibition, as well as formation of intracellular DNA single strand breaks. Such a broad spectrum of expected antitumor activity makes this class of compounds particularly interesting and worth pursuing in clinical studies. SW 33377 (Win 33377, SR 233377) was so promising in vitro that it was taken into Phase I clinical trials for further evaluation. The compound had undesirable cardiac effects, so new analogs were sought that would have similar antitumor effects without the undesirable side effects. In the present study, two new analogs SW 68210 (WIN 68210), and SW 71425 (WIN 71425) are compared to the antiproliferative action of SW 33377 against a variety of freshly explanted human tumor specimens using an in vitro soft agar cloning system. All compounds were more effective with continuous exposure than 1 hour exposure and a concentration-response effect was evident with all compounds. SW 68210 with continuous exposure showed similar activity to SW 33377 at all concentrations. SW 71425 with continuous exposure was less effective at the lower concentrations but was nearly as effective at 10 microg/ml as the other two compounds and was highly effective at 50 microg/ml. At the 10 microg/ml concentration all compounds were similarly effective against breast, colon, non-small cell lung, and ovarian tumors. The two new analogs, SW 68210 and SW 71425 have activity similar to SW 33377 and are both likely candidates for further development.